Bálint E, Kitka T, Zachar G, Adám A, Hemmings HC, Csillag A.
2004.
Abundance and location of DARPP-32 in striato-tegmental circuits of domestic chicks.. J Chem Neuroanat. 28(1-2):27-36.
Girault JA, Hemmings HC, Zorn SH, Gustafson EL, Greengard P.
1990.
Characterization in mammalian brain of a DARPP-32 serine kinase identical to casein kinase II.. J Neurochem. 55(5):1772-83.
Hemmings HC, Greengard P.
1986.
DARPP-32, a dopamine-regulated phosphoprotein.. Prog Brain Res. 69:149-59.
Meister B, Fryckstedt J, Schalling M, Cortés R, Hökfelt T, Aperia A, Hemmings HC, Nairn AC, Ehrlich M, Greengard P.
1989.
Dopamine- and cAMP-regulated phosphoprotein (DARPP-32) and dopamine DA1 agonist-sensitive Na+,K+-ATPase in renal tubule cells.. Proc Natl Acad Sci U S A. 86(20):8068-72.
Ouimet CC, Hemmings HC, Greengard P.
1988.
Dopamine-regulated protein phosphorylation in the basal ganglia.. Adv Exp Med Biol. 235:1-17.
Caporaso GL, Bibb JA, Snyder GL, Valle C, Rakhilin S, Fienberg AA, Hemmings HC, Nairn AC, Greengard P.
2000.
Drugs of abuse modulate the phosphorylation of ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in the basal ganglia.. Neuropharmacology. 39(9):1637-44.
Mayerhofer A, Hemmings HC, Snyder GL, Greengard P, Boddien S, Berg U, Brucker C.
1999.
Functional dopamine-1 receptors and DARPP-32 are expressed in human ovary and granulosa luteal cells in vitro.. J Clin Endocrinol Metab. 84(1):257-64.